Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pam Becker

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Occupational Therapy International|June 16, 2012
Playground usability: what do playground users say?Jacquie Ripat, Pam Becker
British Journal of Haematology|November 19, 2009
Phase 2 study of two sequential three-drug combinations containing bortezomib, cyclophosphamide and dexamethasone, followed by bortezomib, thalidomide and dexamethasone as frontline therapy for multiple myelomaWilliam I Bensinger, Sundar Jagannath, Robert Vescio, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Occupational Therapy International|June 16, 2012
Playground usability: what do playground users say?Jacquie Ripat, Pam Becker
British Journal of Haematology|November 19, 2009
Phase 2 study of two sequential three-drug combinations containing bortezomib, cyclophosphamide and dexamethasone, followed by bortezomib, thalidomide and dexamethasone as frontline therapy for multiple myelomaWilliam I Bensinger, Sundar Jagannath, Robert Vescio, et al.
Pageof 1